leadf
logo-loader
viewXPhyto Therapeutics Corp.

XPhyto prepares to go public and be a dominant cannabis player in Germany.

XPhyto Therapeutics CEO Hugh Rogers sat down with Proactive Vancouver to discuss their cannabis company that is preparing to go public. Rogers talked about their infrastructure set up in Germany and the licensing they have just received.

Rogers also talked about their working relationship with an Alberta university and how that fits in with their overall vision.

Quick facts: XPhyto Therapeutics Corp.

Price: 2.72 CAD

CSE:XPHY
Market: CSE
Market Cap: $157.79 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of XPhyto Therapeutics Corp. named herein, including the promotion by the Company of XPhyto Therapeutics Corp. in any Content on the Site, the...

FOR OUR FULL DISCLAIMER CLICK HERE

Xphyto Therapeutics provides update on their rapid COVID-19 screening test...

Xphyto Therapeutics (CSE: XPHY-OTC: XPHYF) CEO Hugh Rogers joined Steve Darling from Proactive Vancouver with news the company is releasing new details about their rapid, disposable, point-of-care lateral flow screening test to detect COVID-19. Rogers discusses what stage that testing is at...

1 week, 6 days ago

2 min read